Corbett R
Department of Biological Research, Neuroscience SBU, Hoechst-Roussel Pharmaceuticals, Inc., North, Somerville, NJ 08876, USA.
Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):561-4. doi: 10.1016/0091-3057(95)00072-5.
The noncompetitive N-methyl-D-aspartate (NMDA) antagonist dizocilpine (MK-801) produced an interoceptive stimulus cue in rats trained to discriminate between MK-801 (0.075 mg/kg) and saline in a two-choice, discrete trial avoidance paradigm. Haloperidol (0.03-0.3 mg/kg) failed to antagonize the discriminative stimulus cue of MK-801, with all rats choosing the MK-801-appropriate choice lever. Higher doses of haloperidol (1.0 mg/kg) produced significant sedation such that the rats were unable to complete all the trials. In contrast, clozapine dose dependently antagoinzed the discriminative stimulus cue produced by MK-801. Clozapine at a dose of 3.0 mg/kg completely antagonized the stimulus cue produced by MK-801. Therefore, the discriminative stimulus cue produced by the noncompetitive NMDA antagonist MK-801 may be useful as an animal model for selecting novel drugs with potential efficacy for treatment-resistant schizophrenia.
在一种双选、离散试验回避范式中,训练大鼠区分0.075毫克/千克的非竞争性N-甲基-D-天冬氨酸(NMDA)拮抗剂地佐环平(MK-801)和生理盐水,非竞争性NMDA拮抗剂地佐环平(MK-801)在这些大鼠中产生了一种内感受性刺激线索。氟哌啶醇(0.03 - 0.3毫克/千克)未能拮抗MK-801的辨别性刺激线索,所有大鼠都选择了与MK-801对应的选择杆。更高剂量的氟哌啶醇(1.0毫克/千克)产生了显著的镇静作用,以至于大鼠无法完成所有试验。相比之下,氯氮平剂量依赖性地拮抗MK-801产生的辨别性刺激线索。3.0毫克/千克剂量的氯氮平完全拮抗了MK-801产生的刺激线索。因此,非竞争性NMDA拮抗剂MK-801产生的辨别性刺激线索可能作为一种动物模型,用于筛选对难治性精神分裂症具有潜在疗效的新型药物。